Abstract B30: The RNA-binding protein LARP1 is a cancer therapeutic target
Essam Ghazaly(Queen Mary University of London), Sarah P. Blagden(Churchill Hospital), Gabriel Lopez‐Berestein(The University of Texas MD Anderson Cancer Center), John Le Quesne, Dahai Jiang(The University of Texas MD Anderson Cancer Center), Manuela Mura(Ovarian Cancer Action), Chathunissa Gnanaranjan(Queen Mary University of London), Anil K. Sood(The Ohio State University Wexner Medical Center), James Chettle(University of Oxford), Cristian Rodriguez‐Aguayo(The University of Texas MD Anderson Cancer Center), Selanere L. Mangala(Food Research Institute), Chara Stavraka(King's College London)
Cited by 1
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Paraneoplastic Thrombocytosis in Ovarian Cancer
|New England Journal of Medicine|2012|822
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
|New England Journal of Medicine|2008|719